Showing results (801-810 of 1,007) with videos related to

Sort By:
Pageof 101
Parkinsonism & Related Disorders|October 17, 2016
Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1Anne-Marie A Wills, Jordan J Elm, Rong Ye, et al.
Annals of Neurology|May 7, 2014
Mutant huntingtin is present in neuronal grafts in Huntington disease patientsFrancesca Cicchetti, Steve Lacroix, Giulia Cisbani, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 6, 2011
Natural tri- to hexapeptides self-assemble in water to amyloid beta-type fiber aggregates by unexpected alpha-helical intermediate structuresCharlotte A E Hauser, Rensheng Deng, Archana Mishra, et al.
Bioorganic & Medicinal Chemistry Letters|January 29, 2013
Pharmacological properties and predicted binding mode of arylmethylene quinuclidine-like derivatives at the α3β4 nicotinic acetylcholine receptor (nAChR)David C Kombo, Terry A Hauser, Vladimir P Grinevich, et al.
Journal of Cardiology|April 25, 2013
Transcatheter aortic valve implantation improves outcome compared to open-heart surgery in kidney transplant recipients requiring aortic valve replacementHenrik Fox, Stefan Büttner, Katrin Hemmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2000
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathologyT B Freeman, F Cicchetti, R A Hauser, et al.
Vaccines|April 23, 2022
Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral ResponseSammy Patyna, Timon Eckes, Benjamin F Koch, et al.
Transplantation|January 12, 2012
Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder RegistryHeiner Zimmermann, Ilske Oschlies, Susanne Fink, et al.
Frontiers in Neurology|March 14, 2022
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyRobert A Hauser, Hadas Barkay, Hubert H Fernandez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2016
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's diseasePeter A LeWitt, Robert A Hauser, Donald G Grosset, et al.
Pageof 101